Use of pharmaceutical compounds that have an NMDA antagonist activity for the preparation of a Medicament for the treatment of irritable bowel syndrome (IBS), and Pharmaceutical compositions

摘要

The invention relates to the use of pharmaceutical compounds having NMDA antagonist activity for treating certain conditions in the gastrointestinal tract, such as functional gastrointestinal disorders, and in particular irritable bowel syndrome (IBS). The invention also relates to pharmaceutical compositions to be used in the treatment of IBS and product comprising such compounds and a pharmaceutical acceptable carrier.